About this episode
Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s. Learn: Weight loss and glycemic differences between tirzepatide and semaglutide What the FDA is thinking for compounded GLP-1s If you're not on Dr. Spencer's virtual clinic waitlist, click here Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.